+44 (0)20 3910 4640 hello@symmetron.net

Your Partners in Market Access

We are a global consulting firm focused on payer strategy and market access in the pharmaceutical and biotech markets. We work closely with our clients to develop their global value strategy, engage key opinion leaders, generate evidence, and develop pricing strategies that reflect the value of their product.

Evidence Development

Systematic literature reviews

Rapid and pragmatic literature reviews

Strategic evidence searches

Environmental scans

Health Economic Modelling

Early-stage economic evaluations

Global cost-effectiveness models

Local country adaptations

Budget impact models

Health Technology Assessment

Reimbursement submissions

Advisory boards

Strategy 

 

Statistical Analysis

Network meta-analysis

Matching-adjusted indirect comparison

Trial data analysis

Survival analysis

Publications

Strategic publication planning

Manuscripts for peer review 

Poster design and production

Podium presentations

Market Access

Reimbursement strategy

Evidence-based value communication

Key opinion leader engagement

 

We can help you

^

Map the natural history and treatment pathway of a disease

^

Determine unmet need by characterizing the burden of illness

^

Identify and quantify comparative effectiveness and other outcomes

^

Develop original or adapted cost-effectiveness models to demonstrate the value of an intervention

^

Evaluate the value of additional evidence to support product value propositions

From Our Clients

"I have worked with Symmetron on HTAs for NICE and SMC and found the team professional, flexible in responding to my needs and willing to go the extra mile to deliver on our desired outcomes. I look forward to working with them again."

Director of Market Access & External Affairs

LEO Pharma UK

"Symmetron has led the development of several complex economic models for us over several years and has always delivered rigorous research and rock-solid timely results. All output always stood up to HTA scrutiny and what I admired most is how well Symmetron managed not only the development of the model, but also the KOL alignment meetings. A tremendous pleasure to work with and a relaxing experience."

Director of Global Health Economics and Outcomes Research

Medical Device Company

Let's Start Something new
Say Hello!